Skip to main content
Journal of Patient-Reported Outcomes
Fig. 4 | Journal of Patient-Reported Outcomes

Fig. 4

From: Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial

Fig. 4

Spearman correlations between PKDD, PKDIA, and other co-validating scores at baseline. EQ-5D-5L UK United Kingdom-normed European quality of life 5-dimension score, EQ-5D-5L US United States-normed European quality of life 5-dimension score, FACT-An Functional Assessment of Cancer Therapy Anemia, MCS-12 12-item mental component summary, PCS-12 12-item physical component summary, PGIS patient global impression of severity, PKDD Pyruvate Kinase Deficiency Diary, PKDIA Pyruvate Kinase Deficiency Impact Assessment

Back to article page